Skip to main content
medRxiv
  • Home
  • About
  • Submit
  • ALERTS / RSS
Advanced Search

A comparison study of SARS-CoV-2 IgG antibody between male and female COVID-19 patients: a possible reason underlying different outcome between gender

Fanfan Zeng, Chan Dai, Pengcheng Cai, Jinbiao Wang, Lei Xu, Jianyu Li, Guoyun Hu, Lin Wang
doi: https://doi.org/10.1101/2020.03.26.20040709
Fanfan Zeng
1Department of Clinical Laboratory, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei, PR China
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Chan Dai
2Department of Immunology, School of Basic Medicine, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei, PR China
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Pengcheng Cai
1Department of Clinical Laboratory, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei, PR China
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jinbiao Wang
1Department of Clinical Laboratory, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei, PR China
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Lei Xu
1Department of Clinical Laboratory, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei, PR China
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jianyu Li
1Department of Clinical Laboratory, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei, PR China
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Guoyun Hu
1Department of Clinical Laboratory, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei, PR China
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Lin Wang
1Department of Clinical Laboratory, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei, PR China
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: lin_Wang@hust.edu.cn
  • Abstract
  • Full Text
  • Info/History
  • Metrics
  • Data/Code
  • Preview PDF
Loading

Abstract

Objective To compare the difference of SARS-CoV-2 IgG antibody between male and female COVID-19 patients and figure out a possible explanation for different outcome between male and female patients.

Methods A total number of 331 patients confirmed SARS-CoV-2 infection were enrolled. The plasma of these patients were collected during hospitalization and were detected for SARS-CoV-2 IgG antibody. Afterwards, the difference of IgG antibody between male and female patients was analyzed.

Results The level of IgG antibody in mild, general and recovering patients showed on difference between male and female. In severe status, the average IgG antibody level in female patients tended to be higher than that of in male patients. Compared with male patients, most of the female patients generated a relatively high level of SARS-CoV-2 IgG antibody in severe status. In addition, the generation of IgG antibody in female tended to be stronger than male patients in disease early phase.

Conclusions The inconsistent of SARS-CoV-2 IgG antibody generation in male and female patients may account for the different outcome of COVID-19 between gender.

Competing Interest Statement

The authors have declared no competing interest.

Funding Statement

There was no funding support in this work.

Author Declarations

All relevant ethical guidelines have been followed; any necessary IRB and/or ethics committee approvals have been obtained and details of the IRB/oversight body are included in the manuscript.

Yes

All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.

Yes

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Yes

I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.

Yes

Data Availability

The data are available from the author upon request.

Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission.
Back to top
PreviousNext
Posted March 27, 2020.
Download PDF
Data/Code
Email

Thank you for your interest in spreading the word about medRxiv.

NOTE: Your email address is requested solely to identify you as the sender of this article.

Enter multiple addresses on separate lines or separate them with commas.
A comparison study of SARS-CoV-2 IgG antibody between male and female COVID-19 patients: a possible reason underlying different outcome between gender
(Your Name) has forwarded a page to you from medRxiv
(Your Name) thought you would like to see this page from the medRxiv website.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
A comparison study of SARS-CoV-2 IgG antibody between male and female COVID-19 patients: a possible reason underlying different outcome between gender
Fanfan Zeng, Chan Dai, Pengcheng Cai, Jinbiao Wang, Lei Xu, Jianyu Li, Guoyun Hu, Lin Wang
medRxiv 2020.03.26.20040709; doi: https://doi.org/10.1101/2020.03.26.20040709
Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
Citation Tools
A comparison study of SARS-CoV-2 IgG antibody between male and female COVID-19 patients: a possible reason underlying different outcome between gender
Fanfan Zeng, Chan Dai, Pengcheng Cai, Jinbiao Wang, Lei Xu, Jianyu Li, Guoyun Hu, Lin Wang
medRxiv 2020.03.26.20040709; doi: https://doi.org/10.1101/2020.03.26.20040709

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Subject Area

  • Infectious Diseases (except HIV/AIDS)
Subject Areas
All Articles
  • Addiction Medicine (62)
  • Allergy and Immunology (140)
  • Anesthesia (44)
  • Cardiovascular Medicine (404)
  • Dentistry and Oral Medicine (66)
  • Dermatology (47)
  • Emergency Medicine (141)
  • Endocrinology (including Diabetes Mellitus and Metabolic Disease) (168)
  • Epidemiology (4774)
  • Forensic Medicine (2)
  • Gastroenterology (173)
  • Genetic and Genomic Medicine (667)
  • Geriatric Medicine (69)
  • Health Economics (187)
  • Health Informatics (615)
  • Health Policy (312)
  • Health Systems and Quality Improvement (198)
  • Hematology (83)
  • HIV/AIDS (155)
  • Infectious Diseases (except HIV/AIDS) (5244)
  • Intensive Care and Critical Care Medicine (322)
  • Medical Education (88)
  • Medical Ethics (23)
  • Nephrology (72)
  • Neurology (674)
  • Nursing (41)
  • Nutrition (109)
  • Obstetrics and Gynecology (123)
  • Occupational and Environmental Health (203)
  • Oncology (435)
  • Ophthalmology (137)
  • Orthopedics (36)
  • Otolaryngology (88)
  • Pain Medicine (34)
  • Palliative Medicine (15)
  • Pathology (127)
  • Pediatrics (193)
  • Pharmacology and Therapeutics (128)
  • Primary Care Research (82)
  • Psychiatry and Clinical Psychology (757)
  • Public and Global Health (1786)
  • Radiology and Imaging (316)
  • Rehabilitation Medicine and Physical Therapy (135)
  • Respiratory Medicine (254)
  • Rheumatology (86)
  • Sexual and Reproductive Health (67)
  • Sports Medicine (59)
  • Surgery (100)
  • Toxicology (23)
  • Transplantation (28)
  • Urology (37)